Eucure Biopharma Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

Eucure Biopharma General Information

Description

Developer of antibody pharmaceuticals to treat tumors. The company's pharmaceuticals help patients develop checkpoint and cancer growth inhibitors, enabling healthcare professionals to prescribe more effective treatments to patients.

Contact Information

Website
www.eucure.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • Room 1202, Building 5
  • No. 2 Ronghua South Road, Beijing Econcomic and Technological Development Zone
  • Beijing
  • China
+86 010
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Parent Company
Biocytogen Pharmaceuticals (Beijing) Co
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • Room 1202, Building 5
  • No. 2 Ronghua South Road, Beijing Econcomic and Technological Development Zone
  • Beijing
  • China
+86 010

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Eucure Biopharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 24-Sep-2020 Completed Generating Revenue
3. Early Stage VC (Series B) 28-Mar-2018 Completed Startup
2. Early Stage VC (Series A1) 01-Jul-2017 $10.3M $18.8M Completed Startup
1. Early Stage VC (Series A) 14-Dec-2016 $8.51M $8.51M Completed Startup
To view Eucure Biopharma’s complete valuation and funding history, request access »

Eucure Biopharma Former Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
3E Bioventures Capital Venture Capital Minority
BVCF Venture Capital Minority
CMB International Capital Asset Manager Minority
SDIC Venture Capital Venture Capital Minority
To view Eucure Biopharma’s complete investors history, request access »

Ready to get started?

Request a free trial

Eucure Biopharma FAQs

  • When was Eucure Biopharma founded?

    Eucure Biopharma was founded in 2016.

  • Where is Eucure Biopharma headquartered?

    Eucure Biopharma is headquartered in Beijing, China.

  • What industry is Eucure Biopharma in?

    Eucure Biopharma’s primary industry is Drug Discovery.

  • Is Eucure Biopharma a private or public company?

    Eucure Biopharma is a Private company.

  • What is Eucure Biopharma’s current revenue?

    The current revenue for Eucure Biopharma is .

  • How much funding has Eucure Biopharma raised over time?

    Eucure Biopharma has raised $37.8M.

  • Who are Eucure Biopharma’s investors?

    3E Bioventures Capital, BVCF, CMB International Capital, and SDIC Venture Capital have invested in Eucure Biopharma.

  • When was Eucure Biopharma acquired?

    Eucure Biopharma was acquired on 24-Sep-2020.

  • Who acquired Eucure Biopharma?

    Eucure Biopharma was acquired by Biocytogen Pharmaceuticals (Beijing) Co.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process